Literature DB >> 15355741

Gene targeting: roadmap to future therapies.

Lars C Huber1, Thomas Pap, Ulf Müller-Ladner, Renate E Gay, Steffen Gay.   

Abstract

Mesh：

Year:  2004        PMID： 15355741     DOI： 10.1007/s11926-004-0001-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  26 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 2.  Emerging clinical applications of RNA.

Authors:  Bruce A Sullenger; Eli Gilboa
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 3.  Gene therapy for rheumatic diseases.

Authors:  C H Evans; S C Ghivizzani; R Kang; T Muzzonigro; M C Wasko; J H Herndon; P D Robbins
Journal:  Arthritis Rheum       Date:  1999-01

4.  Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

Authors:  G S Firestein; F Echeverri; M Yeo; N J Zvaifler; D R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  The SCID mouse--a novel experimental model for gene therapy in human rheumatoid arthritis.

Authors:  U Müller-Ladner; S Gay
Journal:  Drugs Today (Barc)       Date:  1999 Apr-May       Impact factor: 2.245

6.  Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.

Authors:  W H van der Laan; P H A Quax; C A Seemayer; L G M Huisman; E J Pieterman; J M Grimbergen; J H Verheijen; F C Breedveld; R E Gay; S Gay; T W J Huizinga; T Pap
Journal:  Gene Ther       Date:  2003-02       Impact factor: 5.250

7.  Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.

Authors:  Thomas Pap; Michael Nawrath; Jochen Heinrich; Magnus Bosse; Anja Baier; Klaus M Hummel; Peter Petrow; Stefan Kuchen; Beat A Michel; Renate E Gay; Ulf Müller-Ladner; Karin Moelling; Steffen Gay
Journal:  Arthritis Rheum       Date:  2004-09

8.  Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.

Authors:  S Kuiper; L A Joosten; A M Bendele; C K Edwards; O J Arntz; M M Helsen; F A Van de Loo; W B Van den Berg
Journal:  Cytokine       Date:  1998-09       Impact factor: 3.861

9.  Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis.

Authors:  J Schedel; C A Seemayer; T Pap; M Neidhart; S Kuchen; B A Michel; R E Gay; U Müller-Ladner; S Gay; W Zacharias
Journal:  Gene Ther       Date:  2004-07       Impact factor: 5.250

10.  Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.

Authors:  T Pap; J K Franz; K M Hummel; E Jeisy; R Gay; S Gay
Journal:  Arthritis Res       Date:  2000
View more
  1 in total

1.  Cells of the synovium in rheumatoid arthritis. Macrophages.

Authors:  Raimund W Kinne; Bruno Stuhlmüller; Gerd-R Burmester
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.